David George Kelly - Net Worth and Insider Trading
David George Kelly Net Worth
The estimated net worth of David George Kelly is at least $15 Million dollars as of 2024-09-30. David George Kelly is the EVP & Corporate Secretary of Horizon Therapeutics PLC and owns about 125,888 shares of Horizon Therapeutics PLC (HZNP) stock worth over $15 Million. David George Kelly is also the Director of Iterum Therapeutics PLC and owns about 1,303 shares of Iterum Therapeutics PLC (ITRM) stock worth over $1,375. Details can be seen in David George Kelly's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David George Kelly has not made any transactions after 2018-11-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David George Kelly
David George Kelly Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David George Kelly owns 2 companies in total, including Iterum Therapeutics PLC (ITRM) , and Horizon Therapeutics PLC (HZNP) .
Click here to see the complete history of David George Kelly’s form 4 insider trades.
Insider Ownership Summary of David George Kelly
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ITRM | Iterum Therapeutics PLC | 2019-05-24 | director |
| HZNP | Horizon Therapeutics PLC | 2014-11-06 | EVP & Corporate Secretary |
David George Kelly Latest Holdings Summary
David George Kelly currently owns a total of 2 stocks. Among these stocks, David George Kelly owns 125,888 shares of Horizon Therapeutics PLC (HZNP) as of November 6, 2014, with a value of $15 Million and a weighting of 99.99%. David George Kelly also owns 1,303 shares of Iterum Therapeutics PLC (ITRM) as of November 30, 2018, with a value of $1,375 and a weighting of 0.01%.
Latest Holdings of David George Kelly
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics PLC | 2014-11-06 | 125,888 | 116.30 | 14,640,774 |
| ITRM | Iterum Therapeutics PLC | 2018-11-30 | 1,303 | 1.06 | 1,375 |
Holding Weightings of David George Kelly
David George Kelly Form 4 Trading Tracker
According to the SEC Form 4 filings, David George Kelly has made a total of 0 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years. The most-recent trade in Horizon Therapeutics PLC is the sale of 0 shares on November 6, 2014, which brought David George Kelly around $0.
According to the SEC Form 4 filings, David George Kelly has made a total of 0 transactions in Iterum Therapeutics PLC (ITRM) over the past 5 years. The most-recent trade in Iterum Therapeutics PLC is the acquisition of 667 shares on November 30, 2018, which cost David George Kelly around $62,900.
Insider Trading History of David George Kelly
- 1
David George Kelly Trading Performance
GuruFocus tracks the stock performance after each of David George Kelly's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David George Kelly is -11.64%. GuruFocus also compares David George Kelly's trading performance to market benchmark return within the same time period. The performance of stocks bought by David George Kelly within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David George Kelly's insider trading performs compared to the benchmark.
Performance of David George Kelly
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12.28 | | | | | |
| Relative Return to S&P 500(%) | -2.34 | | | | | |
David George Kelly Ownership Network
David George Kelly Owned Company Details
What does Iterum Therapeutics PLC do?
Who are the key executives at Iterum Therapeutics PLC?
David George Kelly is the director of Iterum Therapeutics PLC. Other key executives at Iterum Therapeutics PLC include Chief Scientific Officer Michael W. Dunne , director & President & CEO Fishman Corey N. , and Chief Medical Officer Sailaja Puttagunta .
Iterum Therapeutics PLC (ITRM) Insider Trades Summary
Over the past 18 months, David George Kelly made no insider transaction in Iterum Therapeutics PLC (ITRM). Other recent insider transactions involving Iterum Therapeutics PLC (ITRM) include a net purchase of 55,000 shares made by Michael W. Dunne , and a net purchase of 10,000 shares made by Fishman Corey N. .
In summary, during the past 3 months, insiders sold 0 shares of Iterum Therapeutics PLC (ITRM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Iterum Therapeutics PLC (ITRM) were sold and 65,000 shares were bought by its insiders, resulting in a net purchase of 65,000 shares.
Iterum Therapeutics PLC (ITRM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Iterum Therapeutics PLC Insider Transactions
David George Kelly Mailing Address
Above is the net worth, insider trading, and ownership report for David George Kelly. You might contact David George Kelly via mailing address: C/o Horizon Pharma Plc, Adelaide Chambers, Peter Street, Dublin 8 L2 None.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
